Keywords: E: T; ADCC; antibody dependent cellular cytotoxicity; ADPh; antibody dependent phagocytosis; BsAb; bispecific antibody; CDC; complement dependent cytotoxicity; CEA; carcinoembryonic antigen; CR3; complement receptor 3; CTL; cytotoxic T-lymphocyte; DC; dendritic
مقالات ISI E: T (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
An improved method to quantify human NK cell-mediated antibody-dependent cell-mediated cytotoxicity (ADCC) per IgG FcR-positive NK cell without purification of NK cells
Keywords: E: T; ADCC; antibody-dependent cell-mediated cytotoxicity; CD16A; cluster of differentiation designation for the Fc-gamma type III low affinity receptor for IgG, found on NK cells; CD20; cluster of differentiation designation for a B cell surface protein; CX1:1
Nitrated T helper cell epitopes enhance the immunogenicity of HER2 vaccine and induce anti-tumor immunity
Keywords: E: T; Human epidermal growth factor receptor 2; Universal T cell epitope; Anti-tumor immunity; Nitration; CTL; cytotoxic T lymphocyte; E:T; effector:target; HER2; Human epidermal growth factor receptor 2; LDH; lactate dehydrogenase; MHC; Major histocompatibilit
Nonlytic Lymphocytes Engineered to Express Virus-Specific T-Cell Receptors Limit HBV Infection by Activating APOBEC3
Keywords: E: T; Antiviral; Immune Response; Immune Therapy; LTB; 3-D; 3-dimensional; AE-T; activated T; APOBEC3; apolipoprotein B mRNA editing enzyme, catalytic polypeptide 3; CAR; chimeric antigen receptor; cccDNA; covalently closed circular DNA; E:T; effector cell-to
Immunization with electroporation enhances the protective effect of a DNA vaccine candidate expressing prME antigen against dengue virus serotype 2 infection
Keywords: E: T; Ab; antibody; ANOVA; analysis of variance; CTL; cytotoxic T lymphocyte; DV; dengue virus; E; envelope; ELISA; enzyme-linked immunosorbent assay; ELISPOT; enzyme-linked immunospot assay; EP; electroporation; E:T; effector:target; FBS; fetal bovine serum; G
Syntaxin 8 is required for efficient lytic granule trafficking in cytotoxic T lymphocytes
Keywords: E: T; CHX; cycloheximide; CTL; Cytotoxic T lymphocytes; E:T; effector to target ratio; FHL; familial HLH; HLH; hemophagocytic lymphohistiocytosis; LDH; lactate dehydrogenase; LG; lytic granules; IS; immunological synapse; qRT-PCR; quantitative real time polymer
Enhanced anti-colon cancer immune responses with modified eEF2-derived peptides
Keywords: E: T; eEF2; eukaryotic elongation factor-2; TAAs; tumor-associated antigens; PBLs; peripheral blood lymphocytes; Tg; transgenic; TCR; T cell receptor; GrB; granzyme B; CTL; cytotoxic T lymphocyte; PBMCs; peripheral blood mononuclear cells; DC; dendritic cell; D
Downregulation of STAT3 phosphorylation enhances tumoricidal effect of IL-15-activated dendritic cell against doxorubicin-resistant lymphoma and leukemia via TNF-α
Keywords: E: T; DL; Dalton lymphoma; DC; dendritic cells; IL-15; interleukin 15; CUB; cucurbitacin I; NDC; DC from normal; DLDC; DC from Dalton lymphoma mice; E:T; effector target ratio; DOX; doxorubicin; DOX-R; doxorubicin resistance; TNF-α; Dendritic cells; IL-15; Dox
T Cells Engineered to Express a T-Cell Receptor Specific for Glypican-3 to Recognize and Kill Hepatoma Cells In Vitro and in Mice
Keywords: E: T; Cancer Immunotherapy; Tumor-Associated Antigens; Liver Cancer; Immune Response; E:T; effector to target cell ratio; GPC3; glypican-3; HCC; hepatocellular carcinoma; HLA; human leukocyte antigen; hTCM; human T-cell medium; IFN; interferon; IL; interleukin;
A novel nonradioactive CFDA assay to monitor the cellular immune response in myeloid leukemia
Keywords: E: T; allo-HSCT; allogeneic hematopoietic stem cell transplantation; AML; acute myeloid leukemia; APC; allophycocyanin; CML; chronic myeloid leukemia; CFDA; 5,6-carboxyfluorescein diacetate succinimidyl ester; DLT; donor lymphocyte transfusions; ELISPOT; enzyme
Identification of a novel HLA-A*24:02-restricted adenovirus serotype 11-specific CD8+ T-cell epitope for adoptive immunotherapy
Keywords: E: T; AdV; adenoviruses; Ad11; adenovirus serotype 11; BIMAS; Bioinformatics and Molecular Analysis Section; CM; culture medium; CMV; cytomegalovirus; CTLs; cytotoxic T-cells; EBV; Epstein-Barr virus; ELISA; enzyme-linked immunosorbent assay; E:T; effector to t
Channel catfish leukocyte immune-type receptor mediated inhibition of cellular cytotoxicity is facilitated by SHP-1-dependent and -independent mechanisms
Keywords: E: T; IpLITRs; Ictalurus punctatus leukocyte immune-type receptors; SH2; Src homology 2; SHP; Src homology 2 domain-containing cytoplasmic phosphatase; Csk; C-terminal Src kinase; ITAM; immune receptor tyrosine-based activation motif; SFK; Src-family protein ty
Visualization and quantification of cytotoxicity mediated by antibodies using imaging flow cytometry
Keywords: E: T; ADCC; antibody-dependent cell-mediated cytotoxicity; ADCP; antibody-dependent cell mediated phagocytosis; E:T; effector to target ratio; CFSE; carboxy-fluorescein diacetate, succinimidyl ester; DRAQ5; 1,5-bis{[2-(di-methylamino) ethyl]amino}-4,8-dihydroxy
A novel four-colour flow cytometric assay to determine natural killer cell or T-cell-mediated cellular cytotoxicity against leukaemic cells in peripheral or bone marrow specimens containing greater than 20% of normal cells
Keywords: E: T; NK; natural killer; aNK; activated natural killer; GvHD; graft versus host-disease; DLI; donor lymphocyte infusions; ALL; acute lymphoblastic leukaemia; AML; acute myeloid leukaemia; JMML; juvenile myelo-monocytoid leukaemia; mAb; monoclonal antibody; FSC